Company Overview and News

49
7 Top S&P 500 Stocks to Consider for Long-Term Gains | InvestorPlace

30m investorplace
The S&P 500 is an index containing the largest stocks in the country. Investors use it to gauge how stocks are doing overall, as it serves as a snapshot for the U.S. equities market. Generally speaking, the index is also used as a benchmark, as everyone from retail investors to hedge fund managers compare their performance to it.
AMD NYTAB NVDA BRK.A JPM GM.WS.A GM.WS.B GM.WS.C GM INTC GM.WSB DAL MMM

73
The Cloud Czars’ Move into Chips Doesn’t Bode Well for Intel Stock

2h investorplace
Intel (NASDAQ:INTC) has been a top chip maker since forever, but there could be trouble looming for Intel stock in the form of the Cloud Czars. It is no longer news that the five of them, Apple (NASDAQ:AAPL), Amazon.com (NASDAQ:AMZN), Alphabet (NASDAQ:GOOGL), Microsoft (NASDAQ:MSFT) and Facebook (NASDAQ:FB), are all in the chip business.
IBM FB AMZN GOOGL AAPL AMD MSFT NVDA QCOM INTC TSM

4
INTC vs. NVDA: Which Stock Is the Better Value Option?

5h zacks
Investors interested in Semiconductor - General stocks are likely familiar with Intel (INTC - Free Report) and Nvidia (NVDA - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
NVDA INTC

23
AMD Second Quarter Earnings Preview

2018-07-16 seekingalpha
Advanced Micro Devices (AMD) will get on the investor radar again when the company reports second quarter earnings later this month. AMD will post results July 25 (per Nasdaq.com). Between now and on that date, the company already has a high bar set by investors. The stock is up 70 percent and is valued at a forward P/E of 26 times. What must AMD report to keep investors happy?
AMD NVDA CRAY

7
The Millennial Portfolio: Longer Than Long Term?

2018-07-16 seekingalpha
I have been working on my Millennial Portfolio for almost two years and have picked out 22 stocks so far.
VTR FB GOOGL WELL NVDA

5
eBay (EBAY) Gears Up for Q2 Earnings: What's in the Cards?

2018-07-16 zacks
eBay Inc. (EBAY - Free Report) is scheduled to report second-quarter 2018 earnings on Jul 18, after the bell.
POOL GTT ASML CSX NVDA EBAY

7
Ericsson (ERIC) to Report Q2 Earnings: What's in the Cards?

2018-07-16 zacks
Ericsson (ERIC - Free Report) is scheduled to report second-quarter 2018 results before the opening bell on Jul 18. The company has a bleak earnings history with consecutive colossal earnings misses. However, Ericsson managed to beat estimates by 4 cents in the last reported quarter with an average negative surprise of 269.2% in the trailing four quarters. Let's see how things are shaping up for this announcement and whether Ericsson can beat earnings this quarter.
CMA.WS POOL CMA GTT VZ NVDA CMPWW VZA

84
4 Stocks With a Razor-Sharp Competitive Edge to Buy

2018-07-13 investorplace
When evaluating stocks to buy, investors tend to look for positive factors that can lead to a competitive edge. Such an edge happens when companies move ahead of their peers in a sector or when they develop a product enhancement or build a market in an existing industry.
FOX JBLU SAVE AMD NFLX NVDA AMZN MU AAPL ALGT FOXA DIS LUV

27
5 Less-Obvious Esports Stocks Investors Should Watch

2018-07-13 investorplace
The fact that gaming is no longer just gaming continues to benefit esports stocks. Esports, or competitions centered on video gaming, has reached new heights in popularity. Since Activision (NASDAQ:ATVI) created its Overwatch League for competitive gaming, esports have increased in popularity.
EA TTWO MU 0700 MSFT NYTAB NVDA INTC DIS ATVI

45
Companies That Have Created the Most Value Over the Past 5 Years

2018-07-13 247wallst
It’s not surprising, perhaps, that technology and media firms have created more value for shareholders over the past five years than have companies in any other sector. What may be surprising is that Apple Inc. (NASDAQ: AAPL) is not among them.
FB AMZN AAPL NFLX SNE NVDA SNEJF

8
Mellanox (MLNX) to Report Q2 Earnings: Is a Beat in Store?

2018-07-13 zacks
Mellanox Technologies, Ltd. (MLNX - Free Report) is set to report fiscal second-quarter 2018 results on Jul 17, 2018. The company beat the Zacks Consensus Estimate in the trailing four quarters, delivering an average positive surprise of 12.9%.
MSCC WDAY MLNX NVDA INTC SAM

4
ADTRAN (ADTN) to Report Q2 Earnings: What's in the Cards?

2018-07-13 zacks
ADTRAN, Inc. (ADTN - Free Report) is scheduled to report second-quarter 2018 results after the closing bell on Jul 17. Although this communication infrastructure provider delivered an average positive surprise of 51.3% in the trailing four quarters, it widely missed earnings estimates in the last quarter. Let's see how things are shaping up for this announcement. Factors to Consider ADTRAN is accelerating the industry’s transition to open, programmable, scalable networks by leveraging its Mosaic Software-Defined Access architecture that combines modern Web-scale technologies with open-source platforms to facilitate rapid innovation in multi-technology, multi-vendor environments.
CMA.WS CMA WDAY ADTN NVDA SAM CMPWW

10
Dopamine and the Weather, Part 2

2018-07-13 zacks
Welcome back to Mind Over Money. I’m Kevin Cook, your field guide and story teller for the fascinating arena of behavioral economics.
ACAD BIIB BLUE CRSP NVDA BLUE SAM

36
3 Key Questions About Advanced Micro Devices Stock Ahead of Earnings

2018-07-12 investorplace
Less than two weeks out from earnings, Advanced Micro Devices, Inc. (NASDAQ:AMD) sits in an interesting spot. AMD stock sits not far from its highest levels in a decade. A big rally (AMD is up over 60% this year) has come without a lot of news. Rather, investors simply seem more optimistic toward the company, particularly newer lines like Ryzen and EPYC.
CAT AAPL AMD SNE NVDA

91
20 Small-Cap Stocks With the Potential for Outsized Gains | InvestorPlace

2018-07-12 investorplace
Some market components, such as small-capitalization companies, require little coaxing. Whether it’s their potential to produce incredible gains, or the chance to get in early on a burgeoning industry, small-cap stocks present enticing opportunities. And while we should all be aware of their highly risky reputation, most investment strategies benefit from their inclusion.
LCI JCP GOOG NVDA OFG.PRB ACLS OFG.PRA PES QNST OFG.PRD OFGIP CVSI CMTL AMZN SSTI VSI BKS WKHS PFH BUD MDCL SORL OFG-B OFG-D DGII OFG-A VUZI BREW KTP GOOGL FLL PETQ TTI OFG

NVDA : NVIDIA Corporation Stock Analysis and Research Report

2017-10-11 - Asif

Starting with a focus on PC graphics, NVIDIA invented the GPU to solve some of the most complex problems in computer science. The company has extended its emphasis in recent years to the revolutionary field of AI. NVIDIA delivers value to its customers through PC, mobile and cloud architectures. Vertical integration enables it to bring together hardware, system software, programmable algorithms, libraries, systems and services to create unique value for the markets it serve. The company specialize in markets in which GPU-based visual computing and accelerated computing platforms can provide enhanced throughput for applications. NVIDIA has two reportable segments - GPU and Tegra Processor - are based on a single underlying graphics architecture. From its proprietary processors, The company have created specialized platforms that target the four large markets where its expertise is critical: Gaming, Professional Visualization, Datacenter, and Automotive. NVIDIA's GPU product brands...

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

13h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

15h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to NVDA / NVIDIA Corp. on message board site Silicon Investor.

AMD, ARMH, INTC, NVDA NVIDIA Corporation (NVDA)
The Singularity, A.I.: Machine u0026 Deep Learning,. and GFA AMD ATI INTC NVDA Moderated
CUSIP: 67066G104